Concepedia

Ilse Vastiau

IV

Statistics

Publications

8

Citations

560

H-Index

8

Active since

2004

Affiliations

GlaxoSmithKline (Belgium)(Current)

KU Leuven

Pfizer (United States)

Universidade Federal de São Paulo

Health Sciences North

Ilse Vastiau is an author at GlaxoSmithKline (Belgium) specializing in vaccination, vaccinology, and infectious diseases.

Publications per year

2004–2019

8

Publications

8

Immune Responses to a Recombinant Glycoprotein E Herpes Zoster Vaccine in Adults Aged 50 Years or Older

Anthony L. Cunningham, Thomas C. Heineman, Himal Lal et al. · The Journal of Infectious Diseases · 2018 · 200 citations · Full text

, , +17

Immunogenicity and Safety of the HZ/su Adjuvanted Herpes Zoster Subunit Vaccine in Adults Previously Vaccinated With a Live Attenuated Herpes Zoster Vaccine

Katrijn Grupping, Laura Cámpora, Martine Douha et al. · The Journal of Infectious Diseases · 2017 · 72 citations · Full text

, , +17

Potential Role for Pex19p in Assembly of PTS-Receptor Docking Complexes

Marc Fransen, Ilse Vastiau, Chantal Brees et al. · Journal of Biological Chemistry · 2004 · 67 citations · Full text

, , +14

Safety profile of the adjuvanted recombinant zoster vaccine: Pooled analysis of two large randomised phase 3 trials

Marta López‐Fauqued, Laura Cámpora, Frédérique Delannois et al. · Vaccine · 2019 · 65 citations · Full text

, , +17

Analysis of Human Pex19p's Domain Structure by Pentapeptide Scanning Mutagenesis

Marc Fransen, Ilse Vastiau, Chantal Brees et al. · Journal of Molecular Biology · 2005 · 64 citations

, , +9

1–5 of 8